Workflow
正丹股份(300641) - 2023 Q1 - 季度财报
ZHENGDANCHEMZHENGDANCHEM(SZ:300641)2023-04-25 16:00

Financial Performance - The company's operating revenue for Q1 2023 was ¥402,271,616.25, a decrease of 17.27% compared to ¥486,264,175.07 in the same period last year[5] - Net profit attributable to shareholders was ¥11,500,932.56, down 63.37% from ¥31,398,929.78 year-on-year[5] - Basic and diluted earnings per share were both ¥0.02, representing a decrease of 66.67% from ¥0.06 in the previous year[5] - Total operating revenue for Q1 2023 was CNY 402,271,616.25, a decrease of 17.3% compared to CNY 486,264,175.07 in the same period last year[21] - Net profit for Q1 2023 was CNY 11,500,932.56, a decline of 63.4% compared to CNY 31,398,929.78 in Q1 2022[22] - Earnings per share for Q1 2023 were CNY 0.02, down from CNY 0.06 in the previous year[23] Cash Flow - The net cash flow from operating activities was ¥3,438,262.80, a significant decline of 96.06% compared to ¥87,175,224.54 in Q1 2022[5] - The company's operating cash flow for the current period is ¥3,438,262.80, a significant decrease of 96.06% compared to ¥87,175,224.54 in the previous period[24] - The cash inflow from sales of goods and services is ¥364,770,327.83, down from ¥421,523,706.78, representing a decrease of 13.49%[24] - The total cash outflow for operating activities is ¥383,967,943.26, an increase from ¥341,336,643.03, indicating a rise of 12.52%[24] - The company received tax refunds amounting to ¥16,774,255.62, which is an increase of 196.61% compared to ¥5,653,539.15 in the previous period[24] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥2,259,857,650.57, an increase of 1.81% from ¥2,219,768,521.22 at the end of the previous year[5] - Total liabilities increased to CNY 704,956,555.74 from CNY 676,552,679.93 year-on-year[19] - The company's total non-current assets were CNY 717,483,198.96, slightly down from CNY 727,187,982.13 in the previous period[19] - The total current assets amounted to RMB 1,542,374,451.61, compared to RMB 1,492,580,539.09 at the beginning of the year, showing an increase of about 3.3%[16] Research and Development - The company reported a 50.68% increase in R&D expenses, totaling ¥2,294,647.44, compared to ¥1,522,849.65 in Q1 2022[9] - Research and development expenses for Q1 2023 were CNY 2,294,613.37, up 50.6% from CNY 1,522,849.65 in Q1 2022[21] Investment Activities - Investment income decreased by 81.37% to ¥654,796.10 from ¥3,514,597.78 in the same period last year[9] - The company experienced a 215.50% increase in net cash flow from investing activities, amounting to ¥323,302,254.15, compared to -¥279,917,167.32 in Q1 2022[9] - Total cash inflow from investment activities is ¥384,450,192.94, up from ¥118,711,197.78, indicating a substantial increase of 223.73%[26] - The net cash flow from investment activities is ¥323,302,254.15, a recovery from a negative cash flow of -¥279,917,167.32 in the previous period[26] Future Outlook - The company is exploring new strategies for market expansion and product development, although specific details were not disclosed in the report[14] - Future guidance and performance outlook will be provided in subsequent reports, focusing on growth and innovation initiatives[14]